Government Pension Fund Global (Norway) cut its stake in Mankind Pharma from 1.29% to 1.06%, selling 9,44,006 shares.
A pharmaceutical company that develops, manufactures, and markets a diverse range of formulations across acute and chronic therapeutic areas alongside consumer healthcare products. Incorporated in 1995, the company operates through multiple distribution channels and disease segments within India's pharmaceutical market. Its portfolio spans prescription medicines, over-the-counter products, and wellness offerings designed to serve diverse patient populations and healthcare needs.
Norway's sovereign wealth fund, managed by Norges Bank Investment Management. World's largest SWF with over USD 2 trillion in assets, invested across 8,700+ companies globally including Indian equities.
